子宮筋腫治療装置市場：技術別、治療方法別-2025年～2030年の世界予測

子宮筋腫治療装置市場は、2023年に5億6,039万米ドルと評価され、2024年には6億1,832万米ドルに達すると予測され、CAGR 10.43％で成長し、2030年には11億2,236万米ドルに達すると予測されています。

子宮筋腫治療機器市場には、子宮筋腫（子宮内の非がん性増殖）の診断と治療のために開発された特殊な医療機器が含まれます。これらの機器は、子宮摘出術のような伝統的な手術法に代わる低侵襲の処置において極めて重要な役割を果たしています。このような装置の必要性は、特に出産適齢期の女性の間で子宮筋腫の有病率が増加していることと、回復時間と手術リスクを軽減する低侵襲処置への嗜好が高まっていることに起因しています。主な用途には、超音波、高周波アブレーション、腹腔鏡装置などの画像診断・治療技術があり、病院、外来手術センター、専門クリニックに供給されています。

市場成長は、より効果的で侵襲性の低い治療選択肢につながる医療技術の進歩、ヘルスケア支出の増加、疾患とその治療選択肢に対する意識の高まりといった要因に影響されます。人口の高齢化やアフリカ系アメリカ人女性の罹患率の上昇といった人口動態の動向も、需要をさらに押し上げています。最近の市場動向としては、診断機器にAIを活用して精度を高め、新興国市場で利用しやすい費用対効果の高いソリューションを開拓することが挙げられます。これらを活用するために、企業は新規デバイスの研究開発に投資し、ヘルスケアプロバイダーと協力して治療経路を改善する必要があります。

しかし、同市場は、高額な機器コスト、償還の課題、規制上のハードルといった限界に直面しており、これがより広範な普及の妨げになる可能性があります。重要な課題として、従来のアプローチよりもこうした新しい治療法を選択することへの患者の認識不足や躊躇があります。革新的な分野としては、外来で利用できる使いやすい機器の開発や、患者へのリーチを拡大するための遠隔医療ソリューションの統合などが挙げられます。市場は競争的でダイナミックであり、新規参入企業は常に破壊的技術を導入しています。利害関係者は、これらの障壁を克服し、この進化する環境において成長を維持するために、継続的な技術革新、戦略的パートナーシップ、教育キャンペーンに注力すべきです。

市場力学：急速に進化する子宮筋腫治療装置市場の主要市場インサイトを公開

子宮筋腫治療装置市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の子宮筋腫の増加
  • 低侵襲デバイスへの嗜好の高まり
  • 技術的に高度な製品の利用増加
• 市場抑制要因
  • 新興経済諸国における必要なインフラの不足
• 市場機会
  • 子宮筋腫診断に関連する認識を高めるための政府や組織による好意的な取り組み
  • 技術的に高度な製品のイントロダクションと開発
• 市場の課題
  • 住民の子宮筋腫診断に対する認知度の低下

ポーターの5つの力：子宮筋腫治療装置市場をナビゲートする戦略ツール

ポーターのファイブフォース（5つの力）は、子宮筋腫治療装置市場の競合情勢を把握するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：子宮筋腫治療装置市場における外部からの影響の把握

外部マクロ環境要因は、子宮筋腫治療装置市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析子宮筋腫治療装置市場における競合情勢の把握

子宮筋腫治療装置市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス子宮筋腫治療装置市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、子宮筋腫治療装置市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨子宮筋腫治療装置市場における成功への道筋を描く

子宮筋腫治療装置市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 子宮筋腫の発生が世界中で増加
    • 低侵襲デバイスへの関心が高まる
    • 技術的に高度な製品の利用の増加
  • 抑制要因
    • 新興経済諸国における必要なインフラの不足
  • 機会
    • 子宮筋腫の診断に関する意識を高めるための政府や団体による好ましい取り組み
    • 技術的に高度な製品のイントロダクションと開発
  • 課題
    • 国民の間でのデバイスに対する認知度の低下
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 子宮筋腫治療装置市場：技術別

• アブレーション技術
  • 凍結療法
  • 水熱アブレーション
  • マイクロ波アブレーション
  • 超音波アブレーション
    • 高強度焦点式超音波
    • MRI誘導集束超音波
• 塞栓術
• 腹腔鏡技術
  • 腹腔鏡下子宮筋腫摘出術
  • 筋融解症
• 外科手術の技術
  • 子宮摘出
  • 子宮筋腫摘出術

第7章 子宮筋腫治療装置市場：治療方法別

• 侵襲的治療
• 低侵襲治療
• 非侵襲的治療

第8章 南北アメリカの子宮筋腫治療装置市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋の子宮筋腫治療装置市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの子宮筋腫治療装置市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Advanced Surgical Concepts
• Boston Scientific Corporation
• Conmed Corporation
• Coopersurgical Inc.
• Gynesonics, Inc.
• Hologic, Inc.
• Insightec Ltd.
• Karl Storz SE & Co. KG
• Medtronic PLC
• Merit Medical Systems, Inc.
• Minerva Surgical, Inc.
• Olympus Corporation
• Pentax Medical
• Smith & Nephew PLC
• Stryker Corporation

LIST OF FIGURES

• FIGURE 1. UTERINE FIBROID TREATMENT DEVICE MARKET RESEARCH PROCESS
• FIGURE 2. UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UTERINE FIBROID TREATMENT DEVICE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. UTERINE FIBROID TREATMENT DEVICE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. UTERINE FIBROID TREATMENT DEVICE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. UTERINE FIBROID TREATMENT DEVICE MARKET DYNAMICS
• TABLE 7. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY CRYOABLATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYDROTHERMAL ABLATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MICROWAVE ABLATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HIGH INTENSITY FOCUSED ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MRI-GUIDED FOCUSED ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY EMBOLIZATION TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC MYOMECTOMY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOLYSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTERECTOMY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOMECTOMY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY INVASIVE TREATMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MINIMALLY INVASIVE TREATMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY NON-INVASIVE TREATMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
• TABLE 49. CANADA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 50. CANADA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 51. CANADA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
• TABLE 52. CANADA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 53. CANADA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 54. CANADA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 57. MEXICO UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
• TABLE 58. MEXICO UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 59. MEXICO UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 60. MEXICO UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 66. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
• TABLE 67. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 72. ASIA-PACIFIC UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
• TABLE 74. ASIA-PACIFIC UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 75. AUSTRALIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 76. AUSTRALIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 77. AUSTRALIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
• TABLE 78. AUSTRALIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 79. AUSTRALIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 80. AUSTRALIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
• TABLE 81. CHINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 82. CHINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 83. CHINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
• TABLE 84. CHINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 85. CHINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 86. CHINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
• TABLE 87. INDIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 88. INDIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 89. INDIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
• TABLE 90. INDIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 91. INDIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 92. INDIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
• TABLE 93. INDONESIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 94. INDONESIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 95. INDONESIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
• TABLE 96. INDONESIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 97. INDONESIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 98. INDONESIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
• TABLE 99. JAPAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 100. JAPAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 101. JAPAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
• TABLE 102. JAPAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 103. JAPAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 104. JAPAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
• TABLE 105. MALAYSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 106. MALAYSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 107. MALAYSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
• TABLE 108. MALAYSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 109. MALAYSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 110. MALAYSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
• TABLE 111. PHILIPPINES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 112. PHILIPPINES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 113. PHILIPPINES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
• TABLE 114. PHILIPPINES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 115. PHILIPPINES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 116. PHILIPPINES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
• TABLE 117. SINGAPORE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 118. SINGAPORE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 119. SINGAPORE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
• TABLE 120. SINGAPORE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 121. SINGAPORE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 122. SINGAPORE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH KOREA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH KOREA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH KOREA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH KOREA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH KOREA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH KOREA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
• TABLE 129. TAIWAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 130. TAIWAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 131. TAIWAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
• TABLE 132. TAIWAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 133. TAIWAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 134. TAIWAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
• TABLE 135. THAILAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 136. THAILAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 137. THAILAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
• TABLE 138. THAILAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 139. THAILAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 140. THAILAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
• TABLE 141. VIETNAM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 142. VIETNAM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 143. VIETNAM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
• TABLE 144. VIETNAM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 145. VIETNAM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 146. VIETNAM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
• TABLE 147. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 148. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 149. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
• TABLE 150. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 154. DENMARK UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 155. DENMARK UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 156. DENMARK UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
• TABLE 157. DENMARK UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 158. DENMARK UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 159. DENMARK UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
• TABLE 160. EGYPT UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 161. EGYPT UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 162. EGYPT UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
• TABLE 163. EGYPT UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 164. EGYPT UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 165. EGYPT UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
• TABLE 166. FINLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 167. FINLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 168. FINLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
• TABLE 169. FINLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 170. FINLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 171. FINLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
• TABLE 172. FRANCE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 173. FRANCE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 174. FRANCE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
• TABLE 175. FRANCE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 176. FRANCE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 177. FRANCE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
• TABLE 178. GERMANY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 179. GERMANY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 180. GERMANY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
• TABLE 181. GERMANY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 182. GERMANY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 183. GERMANY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
• TABLE 184. ISRAEL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 185. ISRAEL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 186. ISRAEL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
• TABLE 187. ISRAEL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 188. ISRAEL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 189. ISRAEL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
• TABLE 190. ITALY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 191. ITALY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 192. ITALY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
• TABLE 193. ITALY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 194. ITALY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 195. ITALY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
• TABLE 196. NETHERLANDS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 197. NETHERLANDS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 198. NETHERLANDS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
• TABLE 199. NETHERLANDS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 200. NETHERLANDS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 201. NETHERLANDS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
• TABLE 202. NIGERIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 203. NIGERIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 204. NIGERIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
• TABLE 205. NIGERIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 206. NIGERIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 207. NIGERIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
• TABLE 208. NORWAY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 209. NORWAY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 210. NORWAY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
• TABLE 211. NORWAY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 212. NORWAY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 213. NORWAY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
• TABLE 214. POLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 215. POLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 216. POLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
• TABLE 217. POLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 218. POLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 219. POLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
• TABLE 220. QATAR UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 221. QATAR UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 222. QATAR UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
• TABLE 223. QATAR UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 224. QATAR UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 225. QATAR UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
• TABLE 226. RUSSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 227. RUSSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 228. RUSSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
• TABLE 229. RUSSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 230. RUSSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 231. RUSSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
• TABLE 232. SAUDI ARABIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 233. SAUDI ARABIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 234. SAUDI ARABIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
• TABLE 235. SAUDI ARABIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 236. SAUDI ARABIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 237. SAUDI ARABIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
• TABLE 238. SOUTH AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 239. SOUTH AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 240. SOUTH AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
• TABLE 241. SOUTH AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 242. SOUTH AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 243. SOUTH AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
• TABLE 244. SPAIN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 245. SPAIN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 246. SPAIN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
• TABLE 247. SPAIN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 248. SPAIN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 249. SPAIN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
• TABLE 250. SWEDEN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 251. SWEDEN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 252. SWEDEN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
• TABLE 253. SWEDEN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 254. SWEDEN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 255. SWEDEN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
• TABLE 256. SWITZERLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 257. SWITZERLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 258. SWITZERLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
• TABLE 259. SWITZERLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 260. SWITZERLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 261. SWITZERLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
• TABLE 262. TURKEY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 263. TURKEY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 264. TURKEY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
• TABLE 265. TURKEY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 266. TURKEY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 267. TURKEY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
• TABLE 268. UNITED ARAB EMIRATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 269. UNITED ARAB EMIRATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 270. UNITED ARAB EMIRATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
• TABLE 271. UNITED ARAB EMIRATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 272. UNITED ARAB EMIRATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 273. UNITED ARAB EMIRATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
• TABLE 274. UNITED KINGDOM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 275. UNITED KINGDOM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 276. UNITED KINGDOM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
• TABLE 277. UNITED KINGDOM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 278. UNITED KINGDOM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 279. UNITED KINGDOM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
• TABLE 280. UTERINE FIBROID TREATMENT DEVICE MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 281. UTERINE FIBROID TREATMENT DEVICE MARKET, FPNV POSITIONING MATRIX, 2023

The Uterine Fibroid Treatment Device Market was valued at USD 560.39 million in 2023, expected to reach USD 618.32 million in 2024, and is projected to grow at a CAGR of 10.43%, to USD 1,122.36 million by 2030.

The uterine fibroid treatment devices market encompasses specialized medical equipment developed for diagnosing and treating uterine fibroids-non-cancerous growths in the uterus. These devices play a pivotal role in minimally invasive procedures that offer alternatives to traditional surgical methods like hysterectomy. The necessity for such devices stems from the increasing prevalence of uterine fibroids, particularly among women of childbearing age, coupled with a rising preference for minimally invasive procedures that reduce recovery time and surgical risks. Primary applications include imaging and treatment technologies such as ultrasound, radiofrequency ablation, and laparoscopic devices, catering to hospitals, ambulatory surgical centers, and specialty clinics.

Market growth is influenced by factors such as advancements in medical technology leading to more effective and less invasive treatment options, increasing healthcare expenditure, and a growing awareness of the condition and its treatment alternatives. Demographic trends, including an aging population and higher incidence rates among African American women, further drive demand. Recent opportunities within the market involve leveraging AI in diagnostic devices to enhance accuracy and developing cost-effective solutions to widen accessibility in emerging markets. To capitalize on these, companies should invest in R&D for novel devices and collaborate with healthcare providers to improve treatment pathways.

However, the market faces limitations such as high device costs, reimbursement challenges, and regulatory hurdles, which may hinder broader adoption. A significant challenge is the lack of awareness and hesitancy among patients to opt for these newer treatment methods over traditional approaches. Innovation areas include the development of user-friendly devices that can be utilized in outpatient settings and the integration of telemedicine solutions to expand patient reach. The market is competitive and dynamic, with new entrants constantly introducing disruptive technologies. Stakeholders should focus on continuous innovation, strategic partnerships, and educational campaigns to overcome these barriers and sustain growth in this evolving landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Uterine Fibroid Treatment Device Market

The Uterine Fibroid Treatment Device Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing occurrence of uterine fibroid worldwide
  • Growing penchant for minimally invasive devices
  • Rising utilization of technologically advanced products
• Market Restraints
  • Shortage of required infrastructure in developing economies
• Market Opportunities
  • Favorable initiatives by governments and organizations to increase awareness pertinent to uterine fibroid diagnosis
  • Introduction and development of technologically advanced products
• Market Challenges
  • Reduced awareness of the device among population

Porter's Five Forces: A Strategic Tool for Navigating the Uterine Fibroid Treatment Device Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Uterine Fibroid Treatment Device Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Uterine Fibroid Treatment Device Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Uterine Fibroid Treatment Device Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Uterine Fibroid Treatment Device Market

A detailed market share analysis in the Uterine Fibroid Treatment Device Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Uterine Fibroid Treatment Device Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Uterine Fibroid Treatment Device Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Uterine Fibroid Treatment Device Market

A strategic analysis of the Uterine Fibroid Treatment Device Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Uterine Fibroid Treatment Device Market, highlighting leading vendors and their innovative profiles. These include Advanced Surgical Concepts, Boston Scientific Corporation, Conmed Corporation, Coopersurgical Inc., Gynesonics, Inc., Hologic, Inc., Insightec Ltd., Karl Storz SE & Co. KG, Medtronic PLC, Merit Medical Systems, Inc., Minerva Surgical, Inc., Olympus Corporation, Pentax Medical, Smith & Nephew PLC, and Stryker Corporation.

Market Segmentation & Coverage

This research report categorizes the Uterine Fibroid Treatment Device Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Technology, market is studied across Ablation Techniques, Embolization Techniques, Laparoscopic Techniques, and Surgical Techniques. The Ablation Techniques is further studied across Cryoablation, Hydrothermal Ablation, Microwave Ablation, and Ultrasound Ablation. The Ultrasound Ablation is further studied across High Intensity Focused Ultrasound and MRI-Guided Focused Ultrasound. The Laparoscopic Techniques is further studied across Laparoscopic Myomectomy and Myolysis. The Surgical Techniques is further studied across Hysterectomy and Myomectomy.
• Based on Mode of Treatment, market is studied across Invasive Treatment, Minimally Invasive Treatment, and Non-Invasive Treatment.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing occurrence of uterine fibroid worldwide
    • 5.1.1.2. Growing penchant for minimally invasive devices
    • 5.1.1.3. Rising utilization of technologically advanced products
  • 5.1.2. Restraints
    • 5.1.2.1. Shortage of required infrastructure in developing economies
  • 5.1.3. Opportunities
    • 5.1.3.1. Favorable initiatives by governments and organizations to increase awareness pertinent to uterine fibroid diagnosis
    • 5.1.3.2. Introduction and development of technologically advanced products
  • 5.1.4. Challenges
    • 5.1.4.1. Reduced awareness of the device among population
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Uterine Fibroid Treatment Device Market, by Technology

• 6.1. Introduction
• 6.2. Ablation Techniques
  • 6.2.1. Cryoablation
  • 6.2.2. Hydrothermal Ablation
  • 6.2.3. Microwave Ablation
  • 6.2.4. Ultrasound Ablation
    • 6.2.4.1. High Intensity Focused Ultrasound
    • 6.2.4.2. MRI-Guided Focused Ultrasound
• 6.3. Embolization Techniques
• 6.4. Laparoscopic Techniques
  • 6.4.1. Laparoscopic Myomectomy
  • 6.4.2. Myolysis
• 6.5. Surgical Techniques
  • 6.5.1. Hysterectomy
  • 6.5.2. Myomectomy

7. Uterine Fibroid Treatment Device Market, by Mode of Treatment

• 7.1. Introduction
• 7.2. Invasive Treatment
• 7.3. Minimally Invasive Treatment
• 7.4. Non-Invasive Treatment

8. Americas Uterine Fibroid Treatment Device Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Uterine Fibroid Treatment Device Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Uterine Fibroid Treatment Device Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Advanced Surgical Concepts
• 2. Boston Scientific Corporation
• 3. Conmed Corporation
• 4. Coopersurgical Inc.
• 5. Gynesonics, Inc.
• 6. Hologic, Inc.
• 7. Insightec Ltd.
• 8. Karl Storz SE & Co. KG
• 9. Medtronic PLC
• 10. Merit Medical Systems, Inc.
• 11. Minerva Surgical, Inc.
• 12. Olympus Corporation
• 13. Pentax Medical
• 14. Smith & Nephew PLC
• 15. Stryker Corporation